1. Home
  2. SVRA vs LIND Comparison

SVRA vs LIND Comparison

Compare SVRA & LIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • LIND
  • Stock Information
  • Founded
  • SVRA 2007
  • LIND 1979
  • Country
  • SVRA United States
  • LIND United States
  • Employees
  • SVRA N/A
  • LIND N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • LIND Transportation Services
  • Sector
  • SVRA Health Care
  • LIND Consumer Discretionary
  • Exchange
  • SVRA Nasdaq
  • LIND Nasdaq
  • Market Cap
  • SVRA 527.2M
  • LIND 618.2M
  • IPO Year
  • SVRA N/A
  • LIND N/A
  • Fundamental
  • Price
  • SVRA $3.41
  • LIND $12.32
  • Analyst Decision
  • SVRA Buy
  • LIND Strong Buy
  • Analyst Count
  • SVRA 8
  • LIND 3
  • Target Price
  • SVRA $6.63
  • LIND $16.67
  • AVG Volume (30 Days)
  • SVRA 1.1M
  • LIND 425.6K
  • Earning Date
  • SVRA 11-11-2025
  • LIND 11-04-2025
  • Dividend Yield
  • SVRA N/A
  • LIND N/A
  • EPS Growth
  • SVRA N/A
  • LIND N/A
  • EPS
  • SVRA N/A
  • LIND N/A
  • Revenue
  • SVRA N/A
  • LIND $702,280,000.00
  • Revenue This Year
  • SVRA N/A
  • LIND $17.93
  • Revenue Next Year
  • SVRA N/A
  • LIND $9.44
  • P/E Ratio
  • SVRA N/A
  • LIND N/A
  • Revenue Growth
  • SVRA N/A
  • LIND 18.74
  • 52 Week Low
  • SVRA $1.89
  • LIND $7.45
  • 52 Week High
  • SVRA $4.30
  • LIND $15.06
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 52.33
  • LIND 38.56
  • Support Level
  • SVRA $3.42
  • LIND $12.12
  • Resistance Level
  • SVRA $3.65
  • LIND $12.51
  • Average True Range (ATR)
  • SVRA 0.12
  • LIND 0.42
  • MACD
  • SVRA -0.04
  • LIND -0.08
  • Stochastic Oscillator
  • SVRA 12.90
  • LIND 14.70

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About LIND Lindblad Expeditions Holdings Inc.

Lindblad Expeditions Holdings Inc provides expedition cruising and adventure travel services. The company operates in two segments: Lindblad and Land Experiences, of which Lindblad generates the vast majority of its revenue. It offers itineraries that feature up-close encounters with wildlife, nature, history, and culture, as well as promote guest empowerment and interactivity. It operates expeditions on intimately-scaled ships and interaction between guests, crew, and the teams of scientists, naturalists, researchers, and photographers that participate in the expeditions. Lindblad operates a fleet of twelve owned expedition ships and five seasonal charter vessels under the Lindblad brand.

Share on Social Networks: